4//SEC Filing
Kropotova Alexandra 4
Accession 0001437749-23-006913
CIK 0001833214other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 4:30 PM ET
Size
4.8 KB
Accession
0001437749-23-006913
Insider Transaction Report
Form 4
Kropotova Alexandra
CHIEF MEDICAL OFFICER
Transactions
- Award
Common Stock
2023-03-14+275,000→ 275,000 total
Footnotes (2)
- [F1]Restricted Stock Unit ("RSU") award under the 2021 Equity Incentive Plan, which vests over a four-year service period, with the first 25% vesting on March 14, 2024, and the remaining vesting in even monthly increments thereafter. The RSU award is subject to the reporting person's continued employment through the vesting date.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Documents
Issuer
SAB Biotherapeutics, Inc.
CIK 0001833214
Entity typeother
Related Parties
1- filerCIK 0001825323
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 4:30 PM ET
- Size
- 4.8 KB